Our leadership

Kapil N. Bhalla, MD, FACP

Director

"Our vision is to be excellent in some areas of abnormal biology of cancer cells, and then become experts in translating that knowledge to the clinic. Based on that knowledge, we want to attract new treatments here in Augusta that can benefit our patients. These treatments are cutting-edge," says Dr. Kapil N. Bhalla, founding director and medical oncologist.

John K. Cowell, PhD, DSc, FRCPath

Associate Center Director for Basic Science

Dr. John K. Cowell, a geneticist, edited the first and second editions of Molecular Biology of Cancer, published by Bios Publishing Corp., Oxford, UK. He also has contributed chapters to some 16 books on cancer biology. A full professor of pathology at MCG, his job at the Cancer Center will be to foster collaborative science among the investigators.

Anand Jillella, MBBS

Associate Center Director for Clinical Affairs and Affiliations

NCI-sponsored trials ask the best questions and are probably the most strictly conducted of the clinical trials, but a particular option may not work for everyone.

"That is why we rigorously test these concepts the way we do," says Dr. Anand Jillella, a medical oncologist.

Mark F. Kochevar, MBA

Associate Center Director for Administration and Governmental Affairs

Mark Kochevar divided most of his career between government service at the National Cancer Institute and the University of Maryland Cancer Center. The opportunity to work under the leadership of Dr. Kapil Bhalla – whom Mr. Kochevar terms "the quintessential translational cancer researcher" – and to build a center from the ground up is extraordinary, he says.